Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Revenue: 2009-2024

Historic Revenue for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Dec 2024 value amounting to $351.4 million.

  • Ironwood Pharmaceuticals' Revenue rose 33.26% to $122.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $339.0 million, marking a year-over-year decrease of 10.42%. This contributed to the annual value of $351.4 million for FY2024, which is 20.63% down from last year.
  • As of FY2024, Ironwood Pharmaceuticals' Revenue stood at $351.4 million, which was down 20.63% from $442.7 million recorded in FY2023.
  • Over the past 5 years, Ironwood Pharmaceuticals' Revenue peaked at $442.7 million during FY2023, and registered a low of $351.4 million during FY2024.
  • For the 3-year period, Ironwood Pharmaceuticals' Revenue averaged around $401.6 million, with its median value being $410.6 million (2022).
  • Its Revenue has fluctuated over the past 5 years, first grew by 7.83% in 2023, then decreased by 20.63% in 2024.
  • Ironwood Pharmaceuticals' Revenue (Yearly) stood at $389.5 million in 2020, then rose by 6.22% to $413.8 million in 2021, then declined by 0.76% to $410.6 million in 2022, then climbed by 7.83% to $442.7 million in 2023, then fell by 20.63% to $351.4 million in 2024.